We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

By LabMedica International staff writers
Posted on 05 Jun 2025

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable. More...

While cancer cell migration plays a central role in metastasis, tracking how cells receive and respond to movement-regulating signals has proven difficult. Now, a newly developed fluorescent probe is helping researchers visualize these signaling dynamics in real time, offering a promising pathway for therapeutic intervention to limit cancer spread.

The study was conducted by researchers at the University of Turku (Turku, Finland), whose work focuses on identifying molecular factors that regulate the metastatic behavior of breast cancer cells. Their recent findings center on the role of the protein phosphatase Shp2—short for “Ship two”—which emerged as a critical regulator of metastasis by influencing how cancer cells interact with surrounding tissues. Using their new fluorescent probe, the research team was able to observe how cancer cells process external signals during migration. The probe highlights real-time signaling events within moving cells, making it possible to monitor the dynamics that drive metastasis. This innovation provided the researchers with deeper insight into Shp2’s function and its role in promoting the invasive capabilities of breast cancer cells.

The team’s study also revealed that certain drugs already in clinical trials for other tumor types could be repurposed to inhibit breast cancer metastasis by targeting Shp2-mediated signaling. While these findings are specific to breast cancer, the researchers believe the implications extend to understanding invasion mechanisms in other solid tumors. The work not only introduces a powerful tool for studying cancer cell movement but also opens up new avenues for potential treatment strategies. The researchers are now actively pursuing therapeutic applications based on these results. The implications of this discovery extend beyond breast cancer alone and may help understand cancer cell invasion from solid tumors more generally.

"Researchers develop color-based probes to detect different events in live cells, but this type of cell-dynamics reporter had not been available before. It has transformed our understanding of what sorts of signaling are needed for cell movement,” said Dr. James Conway, the lead researcher of the team. “These probes often take on names from pop culture references. The lab came up with the name Illusia, drawing from an old Finnish story about a fairy that comes to earth from the rainbow. This gave our work a colorful twist, something we are all seeking in today’s world, as we strive for better treatments.”

Related Links:
University of Turku 


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
New
Francisella Tularensis Test
TULAREMIA VIRCLIA IgG+IgM MONOTEST
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.